Merkel cell carcinoma and HIV infection

EA Engels, M Frisch, JJ Goedert, RJ Biggar, RW Miller - The Lancet, 2002 - thelancet.com
EA Engels, M Frisch, JJ Goedert, RJ Biggar, RW Miller
The Lancet, 2002thelancet.com
Merkel cell carcinoma (MCC) is a rare skin cancer that occurs more frequently after organ
transplantation or B-cell malignancy, conditions of suppressed or disordered immunity. To
assess further whether immune suppression increases MCC risk, we studied its occurrence
in a cohort of 309 365 individuals with acquired immunodeficiency syndrome (AIDS) by
using linked AIDS and cancer registries. We identified six cases of MCC, corresponding to a
relative risk of 13· 4 (95% CI 4· 9–29· 1) compared with the general population. These …
Summary
Merkel cell carcinoma (MCC) is a rare skin cancer that occurs more frequently after organ transplantation or B-cell malignancy, conditions of suppressed or disordered immunity. To assess further whether immune suppression increases MCC risk, we studied its occurrence in a cohort of 309 365 individuals with acquired immunodeficiency syndrome (AIDS) by using linked AIDS and cancer registries. We identified six cases of MCC, corresponding to a relative risk of 13·4 (95% CI 4·9–29·1) compared with the general population. These results suggest that immune suppression induced by the human immunodeficiency virus increases MCC risk.
thelancet.com